Company:  KALA PHARMACEUTICALS, INC ... (KALA)
Form Type:  SC 13G
Filing Date:  1/12/2018 
CIK:  0001479419 
Address:  100 BEAVER STREET
SUITE 201
 
City, State, Zip:  WALTHAM, Massachusetts 02453 
Telephone:  781-996-5252 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$16.59  
Change: 
-0.22 (-1.31%)  
Trade Time: 
May 18  
Market Cap: 
$407.49M
Trade KALA now with 

© 2018  
Description of Business
We are a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle­based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Our MPPs are selectively­sized nanoparticles and have proprietary coatings. We believe that these two key attributes enable even distribution of drug particles on mucosal surfaces and significantly increase drug delivery to target tissues by enhancing mobility of drug particles through mucus and preventing drug particles from becoming trapped and eliminated by mucus. We have applied the MPP technology to loteprednol etabonate, or LE, a corticosteroid designed for ocular applications, resulting in two lead product candidates.
Register and access this filing in:     
  FORM SC 13G
  EXHIBIT 99.A